Rituximab (Anti-CD20 Monoclonal Antibody) in Children with Chronic Refractory Symptomatic Immune Thrombocytopenic Purpura : Efficacy and Safety of Treatment
スポンサーリンク
概要
- 論文の詳細を見る
- 2006-07-15
著者
-
Cesaro Simone
イタリア
-
Locatelli Franco
Pediatric Department University Of Pavia
-
Giordano Paola
Pediatric Department University Of Bari
-
PARODI Emilia
Pediatric Department, University of Torino
-
NOBILI Bruno
Pediatric Department, II University of Napoli
-
PERROTTA Silverio
Pediatric Department, II University of Napoli
-
MATARESE Sofia
Pediatric Department, II University of Napoli
-
RUSSO Giovanna
Pediatric Department, University of Catania
-
LICCIARDELLO Maria
Pediatric Department, University of Catania
-
ZECCA Marco
Pediatric Department, University of Pavia
-
CESARO Simone
Pediatric Department, University of Padova
-
BISOGNO Gianni
Pediatric Department, University of Padova
-
DE MATTIA
Pediatric Department, University of Bari
-
RAMENGHI Ugo
Pediatric Department, University of Torino
-
De Mattia
Pediatric Department University Of Bari
-
Zecca Marco
Pediatric Department University Of Pavia
-
Nobili Bruno
Pediatric Department Ii University Of Napoli
-
Ramenghi Ugo
Pediatric Department University Of Torino
-
Parodi Emilia
Pediatric Department University Of Torino
-
Russo Giovanna
Pediatric Department University Of Catania
-
Matarese Sofia
Pediatric Department Ii University Of Napoli
-
Bisogno Gianni
Pediatric Department University Of Padova
-
Perrotta Silverio
Pediatric Department Ii University Of Napoli
-
Licciardello Maria
Pediatric Department University Of Catania
関連論文
- Rituximab (Anti-CD20 Monoclonal Antibody) in Children with Chronic Refractory Symptomatic Immune Thrombocytopenic Purpura : Efficacy and Safety of Treatment
- Immune reconstitution complicated by CMV retinitis in a pediatric patient who underwent haploidentical CD34+-selected hematopoietic stem cell transplant for acute lymphoblastic leukemia